Clinical Trial Update: Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of preoperative antithrombin supplementation in high-risk cardiopulmonary bypass patients has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery
• Cardiopulmonary Bypass-related Complications

Drugs mentioned

• Antithrombin supplementation (antithrombin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Cardiac Surgery, Cardiopulmonary Bypass | Phase 2 | Status: COMPLETED | Results posted: 2019-02-15